Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Algorithm Information

Hemolytic Uremic Syndrome Secondary to Chemotherapy

MyLikes

MyPaths
Purpose:
To determine if a patient has developed a hemolytic uremic syndrome (HUS) secondary to chemotherapy.
Specialty
  • Hematology Oncology
    Nephrology
    Pharmacology
  • Clinical
Objective
  • Adverse effects
ICD-10
  • T45.1

In order to access the algorithms, please subscribe to a plan that fits your needs.

MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Hemolytic Uremic Syndrome Secondary to Chemotherapy
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.